In the second instalment of our Life Sciences Disputes webinar series, our experts discuss the considerations for life sciences companies in arbitrations.
Paul England introduces A Practitioner's Guide to European Patent Law, a new book taking a different approach to substantive patent law, which was published on 17 October 2019.
Agnieszka Sztoldman discusses new draft regulations on medical devices currently being drawn up by the Polish Ministry of Health.
Josie Miller provides an overview of the law and guidance surrounding the patentability of gene and protein sequences, focusing on the differences between the EU and US regimes.
Judith Krens and Emma Jansen explore the Biogen and Celltrion case, in which the suspension of proceedings pending a decision by the European Patent Office and the assignment of a priority right are discussed, and Paul England looks at invalidity by "uncertainty".